Small Cell Lung Carcinoma Recruiting Phase 2 Trials for Sunitinib (DB01268)

Also known as: Carcinoma, Small Cell Lung

IndicationStatusPhase
DBCOND0003161 (Small Cell Lung Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01306045Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic MalignanciesTreatment